Skip to content

IMAB

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$2.88
−0.69%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
7.97x
Price / sales
—
Price / cash flow
—

Enterprise value

Enterprise value
$211.0M
EV / sales
—
EV / EBITDA
-45.51x
EV / EBIT
-36.85x
Market cap
$235.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026